After reading this note you will be able to define megaloblastic anaemia, list the common Kenyan aetiologies, describe the key clinical features and interpret the basic laboratory work‑up. Remember to verify drug choices, doses and local protocols against the Kenya Ministry of Health guidelines and your hospital formulary.
Definition
Megaloblastic anaemia is a macrocytic anaemia characterised by impaired nuclear maturation of haematopoietic cells, leading to the presence of large, immature red‑cell precursors (megaloblasts) in the bone marrow and hypersegmented neutrophils in peripheral blood.
Anatomy and physiology you need
| Structure | Relevance to megaloblastosis |
|---|---|
| Bone marrow erythroid lineage | Site of DNA synthesis; folate/ B12 deficiency stalls nuclear division while cytoplasm continues to grow → large precursors |
| Gastro‑intestinal mucosa | Primary site of folate absorption (duodenum) and vitamin B12‑intrinsic factor complex formation (terminal ileum) |
| Liver | Stores folate; synthesises transport proteins; impaired function reduces folate availability |
| Kidney | Produces erythropoietin; chronic kidney disease can coexist, worsening anaemia |
| Spleen | Removes abnormal macrocytes; splenomegaly may develop from extramedullary haematopoiesis |
Causes and risk factors
| Category | Kenyan‑relevant examples |
|---|---|
| Nutritional deficiency | Poor diet low in leafy vegetables, chronic alcoholism, pregnancy, lactation |
| Malabsorption | Tropical sprue, celiac disease, post‑gastro‑intestinal surgery, helminthic infestation |
| Drugs & toxins | Antimetabolites (methotrexate, antiretrovirals), anticonvulsants (phenytoin), trimethoprim‑sulfamethoxazole |
| Chronic infections | HIV (direct marrow effect, opportunistic infections), TB (granulomatous infiltration), malaria (hemolysis + folate loss) |
| Autoimmune & inflammatory | Rheumatic diseases with chronic NSAID use, inflammatory bowel disease |
| Hemoglobinopathies & sickle cell | Increased folate turnover due to chronic haemolysis |
| Other systemic illnesses | Chronic liver disease, renal failure, malignancies (especially leukaemia) |
Pathophysiology
Nutrient deficiency / drug inhibition → ↓ tetrahydrofolate or methylcobalamin → ↓ thymidylate synthase activity → ↓ dTMP synthesis → impaired DNA replication → nuclear maturation lag while cytoplasm continues → asynchronous cell growth → megaloblast formation in marrow → release of macro‑ovalocytes & hypersegmented neutrophils → ineffective erythropoiesis → peripheral anaemia and pancytopenia.
Additional contributors in Kenya:
- HIV‑related cytokine dysregulation → marrow suppression.
- Malaria‑induced folate loss → exacerbates dietary deficiency.
- Chronic TB → granulomatous infiltration of ileum → B12 malabsorption.
Clinical features
History – what to ask
| Domain | Key questions | Rationale |
|---|---|---|
| General symptoms | Fatigue, weakness, dyspnoea on exertion, palpitations, dizziness, headache | Reflect reduced oxygen‑carrying capacity and high-output cardiac stress. |
| Gastro‑intestinal | Appetite loss, early satiety, glossitis, sore tongue, dysphagia, abdominal pain, diarrhoea or constipation | Mucosal turnover is rapid; folate‑ or B12‑deficiency produces atrophic glossitis, esophageal inflammation and malabsorption. |
| Neurological | Numbness/tingling, gait instability, memory loss, mood change, depression, visual disturbances | Vitamin B12 deficiency (cobalamin) causes sub‑acute combined degeneration; folate deficiency may give mild neuro‑cognitive changes. |
| Hematologic | Easy bruising, petechiae, bleeding gums, menorrhagia, prior transfusions | Severe macrocytosis can impair platelet production; co‑existent iron deficiency may exaggerate bleeding. |
| Drug / dietary exposure | Use of methotrexate, antiepileptics (phenytoin, carbamazepine), sulfasalazine, trimethoprim‑sulfamethoxazole, oral contraceptives, chronic alcohol, strict vegan diet, prolonged parenteral nutrition | Many drugs antagonise folate metabolism; dietary lack is common in low‑resource settings. |
| Infectious / systemic | HIV status, TB treatment (especially isoniazid), malaria episodes, chronic rheumatic disease, sickle‑cell disease, gastrointestinal infections, prior abdominal surgery | HIV and TB drugs (isoniazid) increase folate demand; malaria and sickle‑cell disease cause hemolysis that can mask macrocytosis. |
| Obstetric / paediatric | Recent pregnancy, lactation, infant feeding practices | Pregnancy increases folate requirement; infants of deficient mothers may develop early anemia. |
| Family / genetic | History of hereditary macrocytosis, pernicious anemia, cobalamin transport defects | Autoimmune gastritis (pernicious anemia) is rare but possible; rare inherited disorders may be relevant. |
Examination – what to look for and why
| Finding | Explanation |
|---|---|
| Pallor (conjunctivae, palms) | Reduced hemoglobin from ineffective erythropoiesis. |
| Glossitis (smooth, beefy‑red tongue) | Rapid turnover of oral mucosa is impaired by folate/B12 deficiency. |
| Angular cheilitis, mouth ulcers | Same mucosal vulnerability. |
| Neurological signs – loss of vibration/position sense, gait ataxia, positive Romberg | Demyelination of dorsal columns and corticospinal tracts in B12 deficiency. |
| Peripheral neuropathy – stocking‑glove paraesthesia | Axonal degeneration due to cobalamin shortage. |
| Jaundice or scleral icterus (mild) | Ineffective erythropoiesis leads to intramedullary hemolysis and bilirubin rise. |
| Splenomegaly (rare) | Extramedullary hematopoiesis when marrow stress is severe. |
| Tachycardia, hyperdynamic precordium | Compensatory response to anemia. |
| Low blood pressure, orthostatic drop | Volume depletion from chronic GI loss or poor intake. |
| Skin changes – hyperpigmentation, vitiligo (if autoimmune gastritis) | Associated autoimmune phenomena. |
Differential diagnosis
| Condition | Points toward it | How to separate from megaloblastic anemia |
|---|---|---|
| Iron‑deficiency anemia | Microcytosis, pica, heavy menstrual loss | Low MCV, low ferritin, high TIBC; absent macro‑ovalocytes. |
| Sideroblastic anemia | History of alcohol, lead exposure, myelodysplasia | Ringed sideroblasts on marrow, normal/high ferritin, elevated iron. |
| Hemolytic anemia (e.g., sickle‑cell, G6PD) | Jaundice, dark urine, episodic pain crises | Low haptoglobin, high LDH, reticulocytosis; normal B12/folate. |
| Anemia of chronic disease | Chronic infection (TB, HIV), inflammation | Low serum iron, low TIBC, normal/high ferritin; normocytic or mildly microcytic. |
| Myelodysplastic syndrome | Elderly, cytopenias, dysplastic cells | Bone‑marrow dysplasia, cytogenetics; may have macrocytosis but no vitamin deficiency. |
| Hypothyroidism | Weight gain, cold intolerance, constipation | Elevated TSH, low free T4; macrocytosis can be present but other features dominate. |
| Alcoholic liver disease | Heavy drinking, hepatomegaly, elevated LFTs | Macrocytosis with normal B12/folate, liver enzymes abnormal. |
Investigations
| Test | What it answers | Interpretation |
|---|---|---|
| CBC with peripheral smear | Cell size, shape, presence of hypersegmented neutrophils | Macrocytosis (MCV > 100 fL) + hypersegmented neutrophils → megaloblastic picture. |
| Serum vitamin B12 | Cobalamin status | Low → B12‑deficiency; borderline may need functional tests. |
| Serum folate (red‑cell folate if available) | Folate stores | Low → folate‑deficiency; red‑cell folate reflects tissue stores better. |
| Homocysteine | Functional B12/folate deficiency | Elevated in both B12 and folate deficiency. |
| Methylmalonic acid (MMA) | Specific for B12 deficiency | Elevated → B12‑deficiency; normal in folate deficiency. |
| Reticulocyte count | Marrow response | Low/normal in megaloblastic anemia (ineffective erythropoiesis). |
| LDH, indirect bilirubin, haptoglobin | Hemolysis vs ineffective erythropoiesis | Mildly raised LDH/indirect bilirubin, normal haptoglobin → intramedullary hemolysis. |
| Anti‑intrinsic factor & anti‑parietal cell antibodies | Autoimmune gastritis (pernicious anemia) | Positive → B12 deficiency due to malabsorption. |
| HIV screen, TB work‑up (GeneXpert, sputum) | Co‑existing infections that increase folate demand or cause drug‑induced deficiency | Positive → address underlying infection. |
| Liver function tests | Alcoholic or hepatic contribution to macrocytosis | Abnormal LFTs suggest alternative/additional cause. |
| Bone‑marrow aspirate (if diagnosis unclear) | Cellular morphology, rule out MDS | Hypercellular marrow with megaloblasts confirms diagnosis; dysplasia points elsewhere. |
Diagnosis and severity
- Confirmatory criteria
- Macrocytic anemia (MCV > 100 fL) on CBC.
- Peripheral smear showing hypersegmented neutrophils and/or oval macro‑ovalocytes.
- Biochemical evidence of deficiency: low serum B12 or low folate or elevated MMA (for B12) / elevated homocysteine.
- Classify the aetiology
- Dietary deficiency – low intake, malnutrition, strict vegan diet.
- Malabsorption – pernicious anemia, tropical sprue, post‑gastrectomy, chronic diarrhoea (malaria, HIV enteropathy).
- Drug‑induced – isoniazid, methotrexate, antiepileptics, antiretrovirals.
- Increased demand – pregnancy, haemolytic states, severe infection (TB, HIV).
- Severity grading (based on hemoglobin)
| Severity | Hb (g/dL) | Clinical implication |
|---|---|---|
| Mild | ≥ 10 | Usually outpatient, monitor for symptoms. |
| Moderate | 8–9.9 | May need short‑term transfusion if symptomatic; start definitive therapy promptly. |
| Severe | < 8 | High risk of cardiac decompensation; consider inpatient care, transfusion, and urgent correction of deficiency. |
- Urgency of treatment
- If neurological signs are present, treat immediately (parenteral B12 if B12‑deficiency suspected) to prevent irreversible damage.
- In isolated folate deficiency without neuro signs, oral folic acid is acceptable, but still start promptly to improve marrow response.
The above approach equips a junior doctor on rotation to recognise, investigate and categorise megaloblastic anaemia in the Kenyan clinical context, ensuring timely therapy and safe monitoring.
Management
| Step | What to do | Rationale / safety notes |
|---|---|---|
| Immediate stabilisation | • Give high‑flow O₂ if dyspnoeic or saturations < 94 % <br>• Transfuse packed red cells only if Hb < 7 g/dL or symptomatic (angina, severe tachycardia, hypotension) | Correct tissue hypoxia; avoid unnecessary transfusion because the underlying defect is reversible. |
| Definitive therapy – folate deficiency | • Start oral folic acid (tablet once daily) immediately; switch to parenteral folate (e.g., folinic acid) if malabsorption, severe ileal disease or inability to take oral meds. | Folate repletion reverses macro‑ovalocytosis within 5‑7 days; oral route works in most patients, parenteral for rapid effect or gut loss. |
| Definitive therapy – vitamin B12 deficiency | • Begin intramuscular cyanocobalamin (or hydroxocobalamin) weekly for 4 weeks, then monthly lifelong. <br>• If oral absorption is possible, give high‑dose oral cyanocobalamin daily. | Parenteral route bypasses intrinsic factor defect; lifelong maintenance prevents relapse. |
| Address precipitating/associated conditions | • Treat HIV (ART), TB (anti‑TB regimen), malaria (artemisinin‑based therapy), rheumatic disease (DMARDs), sickle‑cell crises (hydroxyurea, transfusion) as indicated. | Removing the trigger stops ongoing folate loss or malabsorption. |
| Adjuncts | • Give folic acid supplementation (low‑dose) to all patients on methotrexate, antiepileptics, or with chronic haemolysis. <br>• Counsel on diet rich in leafy greens, legumes, meat, eggs. | Prevents recurrence; dietary advice is essential in low‑resource settings. |
| Monitoring | • CBC & reticulocyte count day 3–5, then weekly until normalisation. <br>• Serum B12 & folate at baseline, repeat if no response. <br>• Watch for hyper‑reflexia or neuropathy worsening after B12 therapy (rare “rebound” phenomenon). | Reticulocytosis indicates marrow response; lack of rise suggests alternative diagnosis. |
| Safety / contraindications | • Do not give folic acid before confirming B12 status if neurological signs are present – it may mask haematologic response while neuropathy progresses. <br>• Avoid high‑dose parenteral folate in known B12 deficiency without B12 replacement. | Prevents irreversible neurologic damage. |
Complications and prognosis
- Reversible haematologic complications – severe anaemia, pancytopenia, high output cardiac failure; improve with correct vitamin replacement.
- Neurologic sequelae – dorsal column dysfunction (paresthesiae, gait ataxia), corticospinal tract signs; may become permanent if B12 deficiency untreated > 6 months.
- Megaloblastic marrow fibrosis – rare, may cause persistent cytopenias.
- Infection risk – neutropenia predisposes to bacterial sepsis, especially in HIV/TB co‑infection.
- Pregnancy outcomes – increased risk of fetal growth restriction, neural‑tube defects if maternal B12/folate deficient.
- Prognosis – excellent when the specific deficiency is identified and treated promptly; delayed therapy in B12 deficiency leads to lasting neurologic deficit.
High‑yield exam points
- Look‑alike conditions: Iron‑deficiency anaemia (microcytic), sideroblastic anaemia (ringed sideroblasts), anaemia of chronic disease (normocytic, low retic).
- Commonest wrong first step: Giving folic acid alone when neurological signs suggest B12 deficiency – examiner expects you to rule out B12 first.
- Bedside examiner questions:
- “What does the peripheral smear show and why?” (macro‑ovalocytes, hypersegmented neutrophils – reflect impaired nuclear maturation).
- “Explain why the patient may have a low reticulocyte count despite severe anaemia.” (DNA synthesis block prevents erythroid precursors from maturing).
- “How would you differentiate folate vs B12 deficiency without labs?” (presence of neuropathy, dorsal column signs points to B12).
Clinical case
Case: 34‑year‑old HIV‑positive woman on first‑line ART presents with 3 weeks of fatigue, glossitis, and tingling in the feet. Examination: pallor, mild jaundice, smooth beefy‑red tongue, decreased vibration sense at the great toe, pulse 112 bpm, BP 100/60 mmHg. CBC shows Hb 6.8 g/dL, MCV 112 fL, platelets 140 × 10⁹/L, neutrophils 1.2 × 10⁹/L. Peripheral smear: macro‑ovalocytes, hypersegmented neutrophils.
Questions
- What is the most likely deficiency and why?
Model answer: Vitamin B12 deficiency – neurological signs (paresthesiae, loss of vibration) and macro‑ovalocytosis point to B12 rather than folate.
- What is the immediate management step?
Model answer: Begin intramuscular cyanocobalamin (parenteral B12) while arranging baseline labs; give O₂ and consider transfusion if symptomatic.
- Which long‑term measure will prevent recurrence in this patient?
Model answer: Lifelong monthly intramuscular B12 (or high‑dose oral if absorption proven) and review ART regimen for drugs that may impair B12 absorption (e.g., zidovudine).
Practice questions
Question 1
A 45‑year‑old man with newly diagnosed TB is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. Two weeks later he develops fatigue, glossitis and a CBC showing Hb 9 g/dL, MCV 108 fL. What is the next best step?
A. Increase iron supplementation
B. Start oral folic acid immediately
C. Add pyridoxine (vit B6) to his regimen
D. Give intramuscular vitamin B12
Answer: B. Start oral folic acid immediately
Explanation: Isoniazid interferes with folate metabolism; early folic acid prevents megaloblastic change.
Question 2
A 28‑year‑old woman with sickle‑cell disease presents with severe anaemia (Hb 5 g/dL) and macro‑ovalocytes on smear. Which feature would most strongly suggest a concurrent folate deficiency rather than a sickle‑cell crisis?
A. Presence of sickled cells on smear
B. Elevated LDH
C. Hypersegmented neutrophils
D. Reticulocyte count > 10 %
Answer: C. Hypersegmented neutrophils
Explanation: Hypersegmentation is characteristic of megaloblastic anaemia and not seen in acute sickle‑cell haemolysis.
Question 3
A patient with known pernicious anaemia presents with worsening gait ataxia despite monthly B12 injections. Which action is most appropriate?
A. Increase the frequency of B12 injections
B. Add high‑dose oral folic acid
C. Order serum methylmalonic acid level
D. Start corticosteroids
Answer: C. Order serum methylmalonic acid level
Explanation: Elevated methylmalonic acid confirms inadequate B12 activity; guides whether dosing adjustment is needed.
Question 4
Which of the following is a contraindication to giving folic acid before confirming vitamin B12 status?
A. Presence of macro‑ovalocytes
B. History of malaria infection
C. Neurological symptoms (paresthesiae)
D. Low platelet count
Answer: C. Neurological symptoms (paresthesiae)
Explanation: Folate can correct the anaemia but will not halt B12‑related neurodamage, potentially delaying needed B12 therapy.
Question 5
A 60‑year‑old farmer from western Kenya presents with anaemia, splenomegaly, and a CBC showing Hb 8 g/dL, MCV 115 fL. Peripheral smear shows macro‑ovalocytes and occasional parasites. Which co‑existing condition most likely contributes to his megaloblastic picture?
A. Chronic malaria infection
B. Iron‑deficiency from hookworm
C. Sickle‑cell trait
D. Acute bacterial sepsis
Answer: A. Chronic malaria infection
Explanation: Repeated malaria episodes cause folate loss through haemolysis and increased demand, predisposing to folate‑deficiency megaloblastic anaemia.
Drafted with AI assistance from standard references and reviewed for structure. Check details against your lecture notes and the Kenya MoH guideline.